The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency

阿片类药物和新出现的 HIV-1 C 亚型启动子变异株对 HIV 神经发病和潜伏期的联合影响

基本信息

  • 批准号:
    9982822
  • 负责人:
  • 金额:
    $ 71.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-08-15 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION: Drug abusers account for a substantial proportion of AIDS cases globally. In fact, approximately 10% of new HIV infections worldwide are attributable to injecting drug use, often of an opiate such as heroin. HIV clade C viruses are responsible for nearly half of the global infections and more than 95% of the infections in India. The innate ability of clade C in establishing an expanding epidemic could be ascribed to its unique biological properties, coupled with co-morbidity of drug abuse, which in turn, could influence the HIV LTR genetic polymorphism. We have recently demonstrated the emergence of 4 NF-κB site promoter variant strains in the subtype C in India. The variant viral strains acquire the molecular strategy of attaining an additional NF-κB (3 sites in the wild type & 4 in the variant strains) or RBEIII (onein the wild type & 2 in the variant strains) binding sites (TFBS) leading to enhanced transcriptional potency of the viral promoter. The TFBS duplication is associated with rapid expansion of the variant virus strains in India over the past decade. In fact, the prevalence of the 4-κB strains i India has increased from 1-2% during 2000-2003 to a staggering 30-35% a decade later. The ability to duplicate the NF-κB motifs appears to be unique to subtype C. Based on these observations, we hypothesize that 4-κB strains of subtype C are more infectious leading to increased immune activation, end-organ pathogenesis and latency in the context of opiates. No systemic studies have assessed the impact of viral variant generation on disease progression, and/or end-organ involvement specifically in the CNS. Such longitudinal studies can only be possible in an animal model of HIV infection and opiate abuse. This proposal brings together investigators with unique strengths in molecular virology, macaque pathogenesis and substance abuse to answer these crucial questions while also addressing the relevance in the context of clade B and C viruses. Specifically, two aims are proposed. SA1: To assess the in vitro replication competence of SHIV clones containing 1, 2, 3 or 4 NF-κB binding sites in the promoter as well as env sequences of both clades B and C viruses. SA 2a: To assess the immune responses and disease pathogenesis in Indian rhesus macaques infected with the SHIV clones (clade B vs. C viruses - generated in SA1) in the absence or presence of ART & opiate dependence. SA 2b: To evaluate the influence of the NF-kB number on viral latency in the presence of ART and opiates.


项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise.
  • DOI:
    10.1186/s12977-021-00572-2
  • 发表时间:
    2021-09-19
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Ali H;Bhange D;Mehta K;Gohil Y;Prajapati HK;Byrareddy SN;Buch S;Ranga U
  • 通讯作者:
    Ranga U
Systems biology analyses reveal enhanced chronic morphine distortion of gut-brain interrelationships in simian human immunodeficiency virus infected rhesus macaques.
  • DOI:
    10.3389/fnins.2022.1001544
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Olwenyi, Omalla A.;Johnson, Samuel D.;Bidokhti, Mehdi;Thakur, Vandana;Pandey, Kabita;Thurman, Michellie;Acharya, Arpan;Uppada, Srijayaprakash;Callen, Shannon;Giavedoni, Luis;Ranga, Udaykumar;Buch, Shilpa J.;Byrareddy, Siddappa N.
  • 通讯作者:
    Byrareddy, Siddappa N.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shilpa J. Buch其他文献

Shilpa J. Buch的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shilpa J. Buch', 18)}}的其他基金

Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates
SIV/cART/可卡因非人灵长类动物病毒持续存在时大脑的单细胞决定因素
  • 批准号:
    10683001
  • 财政年份:
    2023
  • 资助金额:
    $ 71.88万
  • 项目类别:
Title: Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir
标题:阿片类药物和卡博特韦之间的药代动力学、药效学和毒理学相互作用
  • 批准号:
    10686187
  • 财政年份:
    2022
  • 资助金额:
    $ 71.88万
  • 项目类别:
Title: Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir
标题:阿片类药物和卡博特韦之间的药代动力学、药效学和毒理学相互作用
  • 批准号:
    10548530
  • 财政年份:
    2022
  • 资助金额:
    $ 71.88万
  • 项目类别:
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
在单细胞水平上揭示 HIV/阿片类药物对大脑的影响:SIV/cART/吗啡/恒河猴模型中的转录、染色质可及性和储库分析
  • 批准号:
    10665734
  • 财政年份:
    2021
  • 资助金额:
    $ 71.88万
  • 项目类别:
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
在单细胞水平上揭示 HIV/阿片类药物对大脑的影响:SIV/cART/吗啡/恒河猴模型中的转录、染色质可及性和储库分析
  • 批准号:
    10656918
  • 财政年份:
    2021
  • 资助金额:
    $ 71.88万
  • 项目类别:
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
在单细胞水平上揭示 HIV/阿片类药物对大脑的影响:SIV/cART/吗啡/恒河猴模型中的转录、染色质可及性和储库分析
  • 批准号:
    10220475
  • 财政年份:
    2021
  • 资助金额:
    $ 71.88万
  • 项目类别:
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
在单细胞水平上揭示 HIV/阿片类药物对大脑的影响:SIV/cART/吗啡/恒河猴模型中的转录、染色质可及性和储库分析
  • 批准号:
    10469423
  • 财政年份:
    2021
  • 资助金额:
    $ 71.88万
  • 项目类别:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
HIV的分子机制
  • 批准号:
    10161058
  • 财政年份:
    2019
  • 资助金额:
    $ 71.88万
  • 项目类别:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
HIV的分子机制
  • 批准号:
    10450546
  • 财政年份:
    2019
  • 资助金额:
    $ 71.88万
  • 项目类别:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
HIV的分子机制
  • 批准号:
    10846423
  • 财政年份:
    2019
  • 资助金额:
    $ 71.88万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 71.88万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.88万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 71.88万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.88万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 71.88万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 71.88万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.88万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 71.88万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 71.88万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了